Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098839
Status:
COMPLETED
Last Update Posted:
2017-12-12
First Post:
2004-12-08
Brief Title:
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia ALL
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Childhood Acute Lymphoblastic Leukemia |
Keywords: